
Alan S. Chen
Examiner (ID: 1750, Phone: (571)272-4143 , Office: P/2124 )
| Most Active Art Unit | 2125 |
| Art Unit(s) | 2124, 2129, 2182, 2125 |
| Total Applications | 1749 |
| Issued Applications | 1501 |
| Pending Applications | 96 |
| Abandoned Applications | 174 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19065800
[patent_doc_number] => 20240100226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => WATER-SOLUBLE SALT PARTICLE CONTAINING COMPOSITIONS AND POROUS MATERIALS MADE THEREFROM
[patent_app_type] => utility
[patent_app_number] => 18/380350
[patent_app_country] => US
[patent_app_date] => 2023-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18380350
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/380350 | WATER-SOLUBLE SALT PARTICLE CONTAINING COMPOSITIONS AND POROUS MATERIALS MADE THEREFROM | Oct 15, 2023 | Pending |
Array
(
[id] => 19297506
[patent_doc_number] => 20240226071
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => SUSTAINED RELEASE OSMOTIC-CONTROLLED PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/487648
[patent_app_country] => US
[patent_app_date] => 2023-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8267
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18487648
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/487648 | SUSTAINED RELEASE OSMOTIC-CONTROLLED PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF | Oct 14, 2023 | Pending |
Array
(
[id] => 19921791
[patent_doc_number] => 12296050
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Pharmaceutical compositions comprising maralixibat and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/377216
[patent_app_country] => US
[patent_app_date] => 2023-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 39
[patent_no_of_words] => 37446
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18377216
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/377216 | Pharmaceutical compositions comprising maralixibat and uses thereof | Oct 4, 2023 | Issued |
Array
(
[id] => 18901267
[patent_doc_number] => 20240016752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => POLYMERIZED WHEY PROTEIN ENCAPSULATED ANTIOXIDANT COMPOUND AND A PROCESS FOR PREPARATION OF SAME
[patent_app_type] => utility
[patent_app_number] => 18/474553
[patent_app_country] => US
[patent_app_date] => 2023-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18474553
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/474553 | Polymerized whey protein encapsulated antioxidant compound and a process for preparation of same | Sep 25, 2023 | Issued |
Array
(
[id] => 19049180
[patent_doc_number] => 20240091149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING GASTROINTESTINAL ABSORPTION OF ELECTROLYTES
[patent_app_type] => utility
[patent_app_number] => 18/469299
[patent_app_country] => US
[patent_app_date] => 2023-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18469299
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/469299 | COMPOSITIONS AND METHODS FOR IMPROVING GASTROINTESTINAL ABSORPTION OF ELECTROLYTES | Sep 17, 2023 | Pending |
Array
(
[id] => 18829125
[patent_doc_number] => 20230397647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => CHEWABLE DISSOLVABLE NICOTINE TABLET
[patent_app_type] => utility
[patent_app_number] => 18/456763
[patent_app_country] => US
[patent_app_date] => 2023-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18456763
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/456763 | CHEWABLE DISSOLVABLE NICOTINE TABLET | Aug 27, 2023 | Pending |
Array
(
[id] => 18841728
[patent_doc_number] => 20230404131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => DISSOLVABLE-CHEWABLE EXHAUSTED-TOBACCO TABLET
[patent_app_type] => utility
[patent_app_number] => 18/455799
[patent_app_country] => US
[patent_app_date] => 2023-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455799
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/455799 | DISSOLVABLE-CHEWABLE EXHAUSTED-TOBACCO TABLET | Aug 24, 2023 | Pending |
Array
(
[id] => 19622820
[patent_doc_number] => 12161611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Niclosamide formulations and methods of use
[patent_app_type] => utility
[patent_app_number] => 18/455001
[patent_app_country] => US
[patent_app_date] => 2023-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 15734
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455001
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/455001 | Niclosamide formulations and methods of use | Aug 23, 2023 | Issued |
Array
(
[id] => 18815855
[patent_doc_number] => 20230390194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => FORMULATIONS OF NEBIVOLOL
[patent_app_type] => utility
[patent_app_number] => 18/450882
[patent_app_country] => US
[patent_app_date] => 2023-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18450882
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/450882 | Formulations of Nebivolol | Aug 15, 2023 | Issued |
Array
(
[id] => 18921239
[patent_doc_number] => 20240024243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => Fine Dry Particulate Adenosine Compositions and Topical Formulations Including the Same
[patent_app_type] => utility
[patent_app_number] => 18/230840
[patent_app_country] => US
[patent_app_date] => 2023-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18230840
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/230840 | Fine Dry Particulate Adenosine Compositions and Topical Formulations Including the Same | Aug 6, 2023 | Pending |
Array
(
[id] => 20106878
[patent_doc_number] => 12357576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => Formulations of triphenyl calcilytic compounds
[patent_app_type] => utility
[patent_app_number] => 18/216536
[patent_app_country] => US
[patent_app_date] => 2023-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15199
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18216536
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/216536 | Formulations of triphenyl calcilytic compounds | Jun 28, 2023 | Issued |
Array
(
[id] => 19682275
[patent_doc_number] => 20250000820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => ORAL TABLET WITH IMPROVED UNIFORMITY OF CONTENT OF ACTIVES
[patent_app_type] => utility
[patent_app_number] => 18/343849
[patent_app_country] => US
[patent_app_date] => 2023-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18343849
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/343849 | ORAL TABLET WITH IMPROVED UNIFORMITY OF CONTENT OF ACTIVES | Jun 28, 2023 | Pending |
Array
(
[id] => 20437415
[patent_doc_number] => 12508236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Solid nanoparticle with inorganic coating
[patent_app_type] => utility
[patent_app_number] => 18/337729
[patent_app_country] => US
[patent_app_date] => 2023-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 6838
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18337729
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/337729 | Solid nanoparticle with inorganic coating | Jun 19, 2023 | Issued |
Array
(
[id] => 18690869
[patent_doc_number] => 20230321031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => Formulated Cannabis Oil Powder By Nanoemulsifycation, Methods Of Producing And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/209954
[patent_app_country] => US
[patent_app_date] => 2023-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18209954
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/209954 | Formulated Cannabis Oil Powder By Nanoemulsifycation, Methods Of Producing And Uses Thereof | Jun 13, 2023 | Abandoned |
Array
(
[id] => 18806932
[patent_doc_number] => 20230381265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => OLIGOSACCHARIDE FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTS
[patent_app_type] => utility
[patent_app_number] => 18/203134
[patent_app_country] => US
[patent_app_date] => 2023-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18203134
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/203134 | OLIGOSACCHARIDE FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTS | May 29, 2023 | Pending |
Array
(
[id] => 18724167
[patent_doc_number] => 20230338287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => AMLODIPINE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/203266
[patent_app_country] => US
[patent_app_date] => 2023-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18203266
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/203266 | Amlodipine formulations | May 29, 2023 | Issued |
Array
(
[id] => 18769258
[patent_doc_number] => 20230364014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => SELF-ASSEMBLED GELS FOR CONTROLLED DELIVERY OF BIOLOGICS AND METHODS OF MAKING THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/324946
[patent_app_country] => US
[patent_app_date] => 2023-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18324946
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/324946 | SELF-ASSEMBLED GELS FOR CONTROLLED DELIVERY OF BIOLOGICS AND METHODS OF MAKING THEREOF | May 25, 2023 | Abandoned |
Array
(
[id] => 18860078
[patent_doc_number] => 20230414512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same
[patent_app_type] => utility
[patent_app_number] => 18/199832
[patent_app_country] => US
[patent_app_date] => 2023-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18199832
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/199832 | Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same | May 18, 2023 | Pending |
Array
(
[id] => 18769267
[patent_doc_number] => 20230364023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/199614
[patent_app_country] => US
[patent_app_date] => 2023-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18199614
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/199614 | DRUG COMPOSITIONS AND METHODS OF PREPARING THE SAME | May 18, 2023 | Pending |
Array
(
[id] => 19584907
[patent_doc_number] => 20240382464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => Manufacturing Process for Metaxalone Tablets
[patent_app_type] => utility
[patent_app_number] => 18/198266
[patent_app_country] => US
[patent_app_date] => 2023-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18198266
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/198266 | Manufacturing Process for Metaxalone Tablets | May 15, 2023 | Pending |